73360-54-0

73360-54-0 structure

Name: Bupivacaine Hydrochloride
Chemical Name: bupivacaine hydrochloride hydrate
CAS Number: 73360-54-0
Molecular Formula: C₁₈H₃₁ClN₂O₂
Molecular Weight: 342.90
Catalog: API Anesthetic Agents Local anesthetics
Create Date: 2017-01-13 05:08:25
Modify Date: 2026-06-30 18:40:38
Bupivacaine hydrochloride monohydrate is a NMDA receptor inhibitor. Bupivacaine hydrochloride monohydrate can block sodium, L-calcium, and potassium channels. Bupivacaine hydrochloride monohydrate potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine hydrochloride monohydrate can be used for the research of chronic pain[1][2][3].

Name	bupivacaine hydrochloride hydrate
Synonyms	2-Piperidinecboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, hydrochloride, hydrate (1:1:1) Bupivacaine hydrochloride Win 11,318 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrate hydrochloride Bupivacaine HCl H2O IP//BP 1-butyl-N-(2,6-dimethylphenyl)-2-Piperidinecboxamide hydrochloride hydrate (1:1:1) 1-Butyl-N-(2,6-dimethylphenyl)piperidin-2-cboxamide HCl hydrate (1:1:1) 2-Piperidinecarboxamide,1-butyl-N-(2,6-dimethylphenyl)-,monohydrochloride,monohydrate 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecboxamide hydrochloride hydrate 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide,hydrate,hydrochloride Bupivacaine Hydrochloride Monohydrate 1.0 mg/ml in Methanol (as anhydrous free base) Bupivacaine HCl hydrate 1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-cboxamide hydrochloride hydrate Marcaine (TN) Bupivacaine HCl H2-O

Description	Bupivacaine hydrochloride monohydrate is a NMDA receptor inhibitor. Bupivacaine hydrochloride monohydrate can block sodium, L-calcium, and potassium channels. Bupivacaine hydrochloride monohydrate potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine hydrochloride monohydrate can be used for the research of chronic pain[1][2][3].
Related Catalog	Signaling Pathways >> Neuronal Signaling >> iGluR Signaling Pathways >> Membrane Transporter/Ion Channel >> Sodium Channel Signaling Pathways >> Membrane Transporter/Ion Channel >> Calcium Channel Research Areas >> Cancer Research Areas >> Neurological Disease Signaling Pathways >> Membrane Transporter/Ion Channel >> Potassium Channel Signaling Pathways >> Membrane Transporter/Ion Channel >> iGluR
Target	NMDA Receptor
References	[1]. Meaghan A Paganelli, et al. Actions of Bupivacaine, a widely used local anesthetic, on NMDA receptor responses. J Neurosci. 2015 Jan 14;35(2):831-42. [2]. Alexander P Schwoerer, et al. A Comparative Analysis of Bupivacaine and Ropivacaine Effects on Human Cardiac SCN5A Channels. Anesth Analg. 2015 Jun;120(6):1226-34. [3]. Carsten Stoetzer, et al. Inhibition of Voltage-Gated Na⁺ Channels by Bupivacaine Is Enhanced by the Adjuvants Buprenorphine, Ketamine, and Clonidine. Reg Anesth Pain Med.Jul/Aug 2017;42(4):462-468.

Symbol	GHS06
Signal Word	Danger
Hazard Statements	H300 + H310 + H330
Precautionary Statements	P260-P264-P280-P284-P301 + P310-P302 + P350
Personal Protective Equipment	Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
Hazard Codes	T+
Risk Phrases	26/27/28
Safety Phrases	22-36/37/39-45
RIDADR	UN 2811 6.1 / PGII
RTECS	TK6125000
Hazard Class	6.1